Cargando…

Correction: Synthetic tetracycline-controllable shRNA targeting long non-coding RNA HOXD-AS1 inhibits the progression of bladder cancer

Detalles Bibliográficos
Autores principales:	Li, Jianfa, Zhuang, Chengle, Liu, Yuchen, Chen, Mingwei, Chen, Yincong, Chen, Zhicong, He, Anbang, Lin, Junhao, Zhan, Yonghao, Liu, Li, Xu, Wen, Zhao, Guoping, Guo, Yinglu, Wu, Hanwei, Cai, Zhiming, Huang, Weiren
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10683158/ https://www.ncbi.nlm.nih.gov/pubmed/38012784 http://dx.doi.org/10.1186/s13046-023-02908-6

Ejemplares similares

Synthetic tetracycline-controllable shRNA targeting long non-coding RNA HOXD-AS1 inhibits the progression of bladder cancer
por: Li, Jianfa, et al.
Publicado: (2016)

shRNA targeting long non-coding RNA CCAT2 controlled by tetracycline-inducible system inhibits progression of bladder cancer cells
por: Li, Jianfa, et al.
Publicado: (2016)

Tetracycline-inducible shRNA targeting long non-coding RNA PVT1 inhibits cell growth and induces apoptosis in bladder cancer cells
por: Zhuang, Chengle, et al.
Publicado: (2015)

Theophylline controllable RNAi-based genetic switches regulate expression of lncRNA TINCR and malignant phenotypes in bladder cancer cells
por: Chen, Zhicong, et al.
Publicado: (2016)

Over-expression of long noncoding RNA BANCR inhibits malignant phenotypes of human bladder cancer
por: He, Anbang, et al.
Publicado: (2016)

Targeting cellular mRNAs translation by CRISPR-Cas9
por: Liu, Yuchen, et al.
Publicado: (2016)

Up-regulation of long non-coding RNA PANDAR is associated with poor prognosis and promotes tumorigenesis in bladder cancer
por: Zhan, Yonghao, et al.
Publicado: (2016)

Correction: Up-regulation of long non-coding RNA PANDAR is associated with poor prognosis and promotes tumorigenesis in bladder cancer
por: Zhan, Yonghao, et al.
Publicado: (2023)

Artificial small RNA for sequence specific cleavage of target RNA through RNase III endonuclease Dicer
por: Xu, Wen, et al.
Publicado: (2016)

Synthetic Tet-inducible artificial microRNAs targeting β-catenin or HIF-1α inhibit malignant phenotypes of bladder cancer cells T24 and 5637
por: Zhan, Yonghao, et al.
Publicado: (2015)

Author Correction: Synthetic Tet-inducible artificial microRNAs targeting β-catenin or HIF-1α inhibit malignant phenotypes of bladder cancer cells T24 and 5637
por: Zhan, Yonghao, et al.
Publicado: (2023)

Inhibiting cell migration and cell invasion by silencing the transcription factor ETS-1 in human bladder cancer
por: Liu, Li, et al.
Publicado: (2016)

Increased lncRNA ABHD11-AS1 represses the malignant phenotypes of bladder cancer
por: Chen, Mingwei, et al.
Publicado: (2017)

Construction of shRNA lentiviral vector
por: Song, Hong, et al.
Publicado: (2010)

Optimized PCR Conditions and Increased shRNA Fold Representation Improve Reproducibility of Pooled shRNA Screens
por: Strezoska, Žaklina, et al.
Publicado: (2012)

Improved siRNA/shRNA Functionality by Mismatched Duplex
por: Wu, Haoquan, et al.
Publicado: (2011)

Long noncoding RNA HOTTIP as a novel predictor of lymph node metastasis and survival in human cancer: a systematic review and meta-analysis
por: Chen, Zhicong, et al.
Publicado: (2016)

Optimization and characterization of tRNA-shRNA expression constructs
por: Scherer, Lisa J., et al.
Publicado: (2007)

Recent development on synthetic biological devices treating bladder cancer
por: Chen, Zhicong, et al.
Publicado: (2016)

shRNA target prediction informed by comprehensive enquiry (SPICE): a supporting system for high-throughput screening of shRNA library
por: Kamatuka, Kenta, et al.
Publicado: (2016)

Synthesizing artificial devices that redirect cellular information at will
por: Liu, Yuchen, et al.
Publicado: (2018)

Long noncoding RNA CCAT2 as a novel biomaker of metastasis and prognosis in human cancer: a meta-analysis
por: Wang, Dailian, et al.
Publicado: (2017)

Delivery of Therapeutic AGT shRNA by PEG-Bu for Hypertension Therapy
por: Wang, Yu-Qiang, et al.
Publicado: (2013)

LncRNA MALAT1 Inhibits Apoptosis and Promotes Invasion by Antagonizing miR-125b in Bladder Cancer Cells
por: Xie, Haibiao, et al.
Publicado: (2017)

Design and cloning strategies for constructing shRNA expression vectors
por: McIntyre, Glen J, et al.
Publicado: (2006)

The effects of stem length and core placement on shRNA activity
por: Mcintyre, Glen J, et al.
Publicado: (2011)

Optimization of Duplex Stability and Terminal Asymmetry for shRNA Design
por: Matveeva, Olga V., et al.
Publicado: (2010)

Energy profile and secondary structure impact shRNA efficacy
por: Zhou, Hong, et al.
Publicado: (2009)

Production of Transgenic Calves Expressing an shRNA Targeting Myostatin
por: Tessanne, K, et al.
Publicado: (2012)

Suppression of Cancer Progression by MGAT1 shRNA Knockdown
por: Beheshti Zavareh, Reza, et al.
Publicado: (2012)

Using shRNA experiments to validate gene regulatory networks
por: Olsen, Catharina, et al.
Publicado: (2015)

Silencing Human Rb2/p130 with shRNA
por: Leucci, Eleonora, et al.
Publicado: (2007)

Stable expression of shRNA for the control of recombinant adenovirus replication
por: Lana, M.V.G., et al.
Publicado: (2023)

Increased expression of SUMO1P3 predicts poor prognosis and promotes tumor growth and metastasis in bladder cancer
por: Zhan, Yonghao, et al.
Publicado: (2016)

Lentivirus-mediated shRNA targeting MUTYH inhibits malignant phenotypes of bladder cancer SW780 cells
por: Gao, Qunjun, et al.
Publicado: (2018)

Specific properties of shRNA-mediated CCR5 downregulation that enhance the inhibition of HIV-1 infection in combination with shRNA targeting HIV-1 rev
por: Cardona, Maria E., et al.
Publicado: (2022)

Synthetic Pre-miRNA-Based shRNA as Potent RNAi Triggers
por: Terasawa, Kazuya, et al.
Publicado: (2011)

RNAi mechanisms in Huntington’s disease therapy: siRNA versus shRNA
por: Aguiar, Sebastian, et al.
Publicado: (2017)

Endogenous MicroRNA Competition as a Mechanism of shRNA-Induced Cardiotoxicity
por: Course, Meredith M., et al.
Publicado: (2019)

Increased expression of ZEB1-AS1 correlates with higher histopathological grade and promotes tumorigenesis in bladder cancer
por: Lin, Junhao, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_se9a2sbsn0ja1alu3feu4dtk92